keyword
MENU ▼
Read by QxMD icon Read
search

genvoya

keyword
https://www.readbyqxmd.com/read/27404190/genvoya-a-new-4-drug-combination-for-hiv
#1
(no author information available yet)
No abstract text is available yet for this article.
July 12, 2016: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/27189707/elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide-a-review-in-hiv-1-infection
#2
Sarah L Greig, Emma D Deeks
Tenofovir alafenamide (tenofovir AF) is a novel oral prodrug of the nucleos(t)ide reverse transcriptase inhibitor (NRTI) tenofovir that has several pharmacological advantages over tenofovir disoproxil fumarate (tenofovir DF), including increased plasma stability and reduced tenofovir systemic exposure. Tenofovir AF has been coformulated with elvitegravir, cobicistat and emtricitabine as a once-daily, single-tablet regimen (elvitegravir/cobicistat/emtricitabine/tenofovir AF; Genvoya(®)) for the treatment of adults and adolescents with HIV-1 infection...
June 2016: Drugs
https://www.readbyqxmd.com/read/27133890/tenofovir-alafenamide-taf-as-the-successor-of-tenofovir-disoproxil-fumarate-tdf
#3
Erik De Clercq
Tenofovir alafenamide (TAF) can be considered a new prodrug of tenofovir (TFV), as successor of tenofovir disoproxil fumarate (TDF). It is in vivo as potent against human immunodeficiency virus (HIV) at a 30-fold lower dose (10mg) than TDF (300mg). TAF has been approved in November 2015 (in the US and EU), as a single-tablet regimen (STR) containing 150mg elvitegravir (E), 150mg cobicistat (C), 200mg emtricitabine [(-)FTC] (F) and 10mg TAF, marketed as Genvoya®, on 01 March 2016 in the US as an STR containing 25mg rilpivirine (R), 200mg F and 25mg TAF, marketed as Odefsey®, and on 4 April 2016 in the US, as an STR containing 200mg F and 25mg TAF, marketed as Descovy®, for the treatment of HIV infections...
November 1, 2016: Biochemical Pharmacology
https://www.readbyqxmd.com/read/26859659/genvoya-a-new-4-drug-combination-for-hiv
#4
(no author information available yet)
No abstract text is available yet for this article.
February 15, 2016: Medical Letter on Drugs and Therapeutics
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"